6550--VISN 16 Lab BPA Point of Care Whole Blood Glucose Testing
This is a Sources Sought notice for market research, not a solicitation, seeking vendors capable of providing blood glucose meters, test strips, and related consumables under a cost-per-test pricing arrangement. The South Central VA Health Care Network intends to establish a firm fixed-price BPA with a one-year base and four one-year options for waived point-of-care whole blood glucose testing devices, including data management, installation, training, and connectivity with the VA VistA Lab Information System. The required equipment must be FDA-approved for professional use, support barcoding, lock-out operators for QC failures, and detect expired test strips, while the data management system must capture, validate, and report QC data and transmit results to VA systems. Performance of services will be at multiple testing sites within each healthcare system, including medical centers and off-site outpatient clinics. No budget amount is specified, and responses are due by June 11, 2026.